Lighthouse Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56M Buy
+42,245
New +$2.46M 0.09% 287
2024
Q4
Sell
-10,004
Closed -$518K 507
2024
Q3
$518K Sell
10,004
-34,722
-78% -$1.63M 0.02% 368
2024
Q2
$1.86M Sell
44,726
-64,343
-59% -$2.88M 0.07% 241
2024
Q1
$5.91M Buy
+109,069
New +$5.56M 0.27% 103

Other funds holding BMY

Lighthouse Investment Partners's BMY Position: Q1 2026 in Review

Lighthouse Investment Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 42,245 shares worth $2.56M. The stake represents 0.09% of the portfolio and ranks #287 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in BMY as recently as Q3 2024.

Lighthouse Investment Partners first reported a position in BMY in Q1 2024 and has held it in 4 quarters since. The position peaked at $5.91M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Lighthouse Investment Partners held 42,245 shares of Bristol-Myers Squibb worth $2.56M as of Q1 2026.
  • Bristol-Myers Squibb was a new Lighthouse Investment Partners position in Q1 2026.
  • Bristol-Myers Squibb made up 0.09% of Lighthouse Investment Partners's portfolio in Q1 2026, its #287 holding.
  • Lighthouse Investment Partners first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 4 quarters since.
  • Lighthouse Investment Partners's Bristol-Myers Squibb position peaked at $5.91M in Q1 2024.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.